EU committee recommends daraxonrasib for metastatic pancreatic cancer
Europe’s CHMP recommends daraxonrasib for pancreatic cancer, HHS and the FDA send a peptide compounding policy to the White House, and the EU committee backs Lilly’s GLP-1 pill.
Former FDA medical officer urges withdrawal of Prader-Willi drug Vykat XR
A former FDA medical officer urges withdrawal of the Prader-Willi drug Vykat XR, the FDA approves pritelivir for refractory herpes, and peptide users report harms as an FDA panel backs wider compounding access.